Trials / Not Yet Recruiting
Not Yet RecruitingNCT05760547
The Translational Initiative to Map Epigenetics in Aging (TIME-A)
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 25,000 (estimated)
- Sponsor
- Elysium Health · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The Translational Initiative to Map Epigenetics in Aging (TIME-A) study aims to advance our understanding of the connections between epigenetics, lifestyle, demographics, and health and aging.
Detailed description
TIME-A is a longitudinal research initiative. Anyone who has ever taken an Index test registered through Elysium Health is eligible to participate. Participation involves answering questions that will be administered via a survey format. Research participants' survey responses will be combined with their epigenetic Index data with the primary aim of identifying the contributions of 1) environmental and lifestyle factors, 2) general health, and 3) medical history, on biological age. Exploratory aims include the development of epigenetic signatures that are predictive of health status, and exploring the relationship between epigenetically-derived health phenotypes and biological age. These findings will lay the foundation for personalized health recommendations using Index (including, but not limited to: workout routines, diets, supplement regimens, medications, lifestyle changes).
Conditions
Timeline
- Start date
- 2023-03-08
- Primary completion
- 2033-03-31
- Completion
- 2033-03-31
- First posted
- 2023-03-08
- Last updated
- 2023-03-08
Source: ClinicalTrials.gov record NCT05760547. Inclusion in this directory is not an endorsement.